145,178 results match your criteria Metastatic Carcinoma


MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response.

Biochim Biophys Acta Mol Basis Dis 2019 Apr 17. Epub 2019 Apr 17.

Scuola Superiore Sant'Anna, Institute of Life Sciences, 56124 Pisa, Italy. Electronic address:

The capacity of inducing angiogenesis is a recognized hallmark of cancer cells. The cancer microenvironment, characterized by hypoxia and inflammatory signals, promotes proliferation, migration and activation of quiescent endothelial cells (EC) from surrounding vascular network. Current anti-angiogenic drugs present side effects, temporary efficacy, and issues of primary resistance, thereby calling for the identification of new therapeutic targets. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09254439193011
Publisher Site
http://dx.doi.org/10.1016/j.bbadis.2019.04.008DOI Listing
April 2019
1 Read

A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: a Case Report.

Hepatology 2019 Apr 20. Epub 2019 Apr 20.

Corporal Michael J Crescenz VA Medical Center, Pathology, 3900 Woodland Avenue, Philadelphia, Pennsylvania, United States.

Nivolumab, an immune checkpoint inhibitor that acts by preventing programmed-death ligand 1 (PD-L1) from binding to the programmed cell death protein-1 (PD-1) receptor, is utilized to treat a variety of cancers including renal cell carcinoma, non-small cell lung cancer, and metastatic melanoma. Currently, nivolumab is FDA-approved as a second-line treatment for advanced hepatocellular carcinoma (HCC) after showing efficacy in patients who progressed on or were intolerant to sorafenib. This article is protected by copyright. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/hep.30659
Publisher Site
http://dx.doi.org/10.1002/hep.30659DOI Listing
April 2019
1 Read

Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.

J Med Case Rep 2019 Apr 20;13(1):95. Epub 2019 Apr 20.

Department of Endocrinology and Metabolism, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.

Background: Papillary thyroid carcinoma is the most common endocrine malignancy. Distant metastasis from differentiated thyroid carcinoma is infrequent and the metastasis rate of papillary thyroid carcinoma is lower than that of follicular thyroid carcinoma. Distant metastases from differentiated thyroid carcinoma are usually seen in the lungs and bones; however, renal metastasis is very rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13256-019-2025-8DOI Listing

Effect of electrochemotherapy with betulinic acid or cisplatin on regulation of heat shock proteins in metastatic human carcinoma cells in vitro.

Oncol Rep 2019 Apr 8. Epub 2019 Apr 8.

Department of Molecular and Cellular Biology, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, 50‑556 Wroclaw, Poland.

Betulinic acid (BTA) is naturally occurring triterpene that has received interest as a novel therapeutic substance with cytotoxicity towards a number of cancer cell lines. Despite the wide spectrum of biological and pharmacological effects, its effect may be limited its lipophobic properties. Therefore, strategies to improve the access of BTA to the cells are required to enhance the anticancer effects. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2019.7103DOI Listing

CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.

Eur Rev Med Pharmacol Sci 2019 Apr;23(7):2817-2826

Department of Otolaryngology Head and Neck Surgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.

Objective: This study aims to explore the biological function of circular RNA ZNF609 (circ-ZNF609) in regulating the occurrence and progression of nasopharyngeal carcinoma (NPC), and to investigate the possible underlying mechanism.

Patients And Methods: The expression levels of circ-ZNF609, microRNA-150-5p and Sp1 in NPC tissues and normal nasopharyngeal epithelial tissues were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Circ-ZNF609 expression was silenced in NPC cell lines (5-8F and HONE-1). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26355/eurrev_201904_17558DOI Listing

Right Heart Mass in Transit with a Hemorrhagic Pericardial Effusion: A Diagnostic Dilemma.

Cureus 2019 Feb 4;11(2):e4009. Epub 2019 Feb 4.

Cardiology, Washington University, Saint Louis, USA.

Metastatic disease to the heart is more often a post-mortem diagnosis due to non-specific symptoms and a low index of suspicion. Our case is a unique presentation of a rare case of cardiac metastasis from oropharyngeal cancer, which eluded echocardiographic diagnosis despite the presence of a hemorrhagic pericardial effusion. The cardiac metastasis, in fact, starts as pericardial seeding, as illustrated by the positron emission tomography (PET) imaging. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.4009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450589PMC
February 2019

Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy.

Case Rep Urol 2019 14;2019:7102504. Epub 2019 Mar 14.

Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA.

Renal cell carcinoma, particularly the most common clear cell type, is one of the most aggressive of urological cancers with significant risk of metastatic spread. It also has a propensity for venotropism with a proportion of tumors developing thrombi up to the right atrium. The response with newly adopted targeted therapy has been considered to be in the evolutionary stage with no clear role with respect to debulking or reducing the size of the inferior vena cava (IVC) thrombus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/7102504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437729PMC

A case of mesenteric panniculitis associated with metastatic poorly differentiated cancer of unknown primary site.

Oxf Med Case Reports 2019 Mar 15;2019(3):omz023. Epub 2019 Apr 15.

Department of General Medicine, Woodlands Health Campus, 2 Yishun Central 2, Singapore.

Mesenteric panniculitis is the inflammation of intestinal mesentery. It may be associated with malignancy. We present a case of mesenteric panniculitis that manifested as unresolved fever which subsequently was found to be due to poorly differentiated metastatic carcinoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/omcr/omz023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463832PMC

Synchronous Primary Malignancy of Female Genital Tract: A Report of Two Cases and Review of Literature.

J Midlife Health 2019 Jan-Mar;10(1):51-54

Department of Pathology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Synchronous primary tumors of female genital tract is a rare phenomenon. We present two cases of anatomically related yet histologically unrelated tumors. The first patient is a 57 years postmenopausal female with synchronous low grade papillary urothelial carcinoma of the bladder and endometrioid adenocarcinoma of the endometrium. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jmh.JMH_138_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459065PMC

Assessing Outcomes and Prognostic Factors for First-Line Therapy in Elderly Patients With Metastatic Renal Cell Carcinoma: Real-Life Data From a Single United Kingdom Institution.

Clin Genitourin Cancer 2019 Mar 27. Epub 2019 Mar 27.

Northampton General Hospital NHS Trust, Cliftonville, Northampton, United Kingdom.

Background: Elderly metastatic renal cell carcinoma (mRCC) patients are under-represented in clinical trials, whose results are therefore difficult to translate into routine management of older patients. We aimed at exploring treatment outcomes and prognostic factors in our real-life elderly mRCC cohort receiving first-line tyrosine kinase inhibitor (TKI) monotherapy.

Patients And Methods: We retrospectively analyzed demographic and clinicopathological characteristics, and treatment data of elderly (≥ 70 years old at first-line start) mRCC patients starting either pazopanib or sunitinib as first-line treatment in our institution between March 2012 and April 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.03.012DOI Listing

Nasopharyngeal carcinoma with cutaneous metastases.

Eur Ann Otorhinolaryngol Head Neck Dis 2019 Apr 15. Epub 2019 Apr 15.

Department of radiotherapy, Farhat Hached hospital, Sousse, Tunisia.

Introduction: Cutaneous metastases from nasopharyngeal carcinoma are extremely rare and associated with a poor prognosis.

Case Reports: We retrospectively reviewed 820 patients with nasopharyngeal carcinoma treated over a 20-year period in the radiotherapy department of Farhat Hached hospital in Sousse and Ibn Khaldoun Medical centre, Hammam Sousse. Two of these patients presented cutaneous metastases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anorl.2019.04.005DOI Listing
April 2019
2 Reads

Risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma.

Phys Med 2019 Apr 25;60:44-49. Epub 2019 Mar 25.

Department of Medical Physics, Faculty of Medicine, University of Crete, P.O. Box 2208, 71003 Iraklion, Crete, Greece.

Purpose: To assess the risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma.

Methods: The study group included 13 females irradiated for breast cancer with 6 MV photons. The plans were initially generated by using standard fractionated (SF) forward-planned IMRT (50 Gy at 2 Gy/fraction). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmp.2019.03.021DOI Listing

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma.

Cancer Res Treat 2019 Apr 16. Epub 2019 Apr 16.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

Purpose: Temsirolimus is effective in the treatment for metastatic non-clear cell renal cell carcinoma (nccRCC) with poor prognosis. We aim to investigate the efficacy and tolerability of temsirolimus in treatment of naïve Asian patients with metastatic/recurrent nccRCC.

Materials And Methods: From January 2008 to July 2017, data of treatment-naïve, metastatic/recurrent nccRCC patients, who were treated with temsirolimus according to the standard protocol, were collected. Read More

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2018.6
Publisher Site
http://dx.doi.org/10.4143/crt.2018.671DOI Listing
April 2019
1 Read

Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys".

Int J Mol Sci 2019 Apr 17;20(8). Epub 2019 Apr 17.

Medical Oncology Department, The Ramón y Cajal Health Research Institute (IRYCIS), CIBERONC, Alcalá University, University Hospital Ramon y Cajal, 28034 Madrid, Spain.

Clear cell renal cell carcinoma (ccRCC) is the seventh most frequently diagnosed tumor in adults in Europe and represents approximately 2.5% of cancer deaths. The molecular biology underlying renal cell carcinoma (RCC) development and progression has been a key milestone in the management of this type of tumor. Read More

View Article

Download full-text PDF

Source
https://www.mdpi.com/1422-0067/20/8/1901
Publisher Site
http://dx.doi.org/10.3390/ijms20081901DOI Listing
April 2019
1 Read

Solitary contralateral adrenal metastasis of renal cell carcinoma 15 years following radical nephrectomy: A case report and review of literature.

Int J Surg Case Rep 2019 Apr 5;58:33-36. Epub 2019 Apr 5.

University of Sulaymaniyah, Faculty of Medical Sciences, School of Medicine, Department of Radiology, Iraq.

Introduction: Renal cell carcinoma (RCC) is known to metastasize to almost every organ. A well-recognized phenomenon in RCC is late metastatic recurrence after nephrectomy which is arbitrarily defined as more than 10 years. The incidence of solitary ipsilateral and contralateral adrenal metastasis is 3% and 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijscr.2019.03.049DOI Listing
April 2019
1 Read

Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients.

Breast Cancer Res Treat 2019 Apr 17. Epub 2019 Apr 17.

Breast Epidemiology Unit, National Institute of Cancer (INCan), Mexico City, Mexico.

Purpose: The aim of this study was to compare the difference in disease-free survival (DFS) and overall survival (OS) between invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) in our Hispanic population with breast cancer (BC).

Methods: We retrospectively analyzed a database of 4533 non-metastatic BC patients treated for BC at the National Cancer Institute in Mexico (INCan) between 2006 and 2016. We compared clinical characteristics, treatment and survival between women with invasive ductal and invasive lobular BC. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-019-05234-8
Publisher Site
http://dx.doi.org/10.1007/s10549-019-05234-8DOI Listing
April 2019
2 Reads

Pancreaticobiliary metastasis presenting as primary mucinous ovarian neoplasm: A systematic literature review.

Gynecol Oncol Rep 2019 May 27;28:109-115. Epub 2019 Mar 27.

Temple University Hospital, Department of Obstetrics, Gynecology, and Reproductive Sciences, 3401 North Broad Street, Philadelphia, PA 19140, United States of America.

True primary mucinous ovarian carcinomas are rarer than originally thought and their clinical behavior and treatment response are different than more common epithelial ovarian carcinomas. Secondary ovarian neoplasms often mimic the clinical and histological features of mucinous ovarian cancer making their diagnosis, and therefore treatment, more difficult. Misdiagnosis can have a significant impact on both treatment and prognosis. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23525789193003
Publisher Site
http://dx.doi.org/10.1016/j.gore.2019.03.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453658PMC
May 2019
1 Read

Verrucous carcinoma arising in a long standing Buschke-Löwenstein tumor.

Clin Case Rep 2019 Apr 19;7(4):836-838. Epub 2019 Feb 19.

Joan C Edwards School of Medicine, Edwards Comprehensive Cancer Center Marshall University Huntington West Virginia.

Giant condyloma acuminatum is a rare variant of genital warts also known as Buschke-Löwenstein tumor. It is characterized by a slow progression of exophytic, ulcerative, and cauliflower-shaped tumor with benign histological features. Verrucous carcinoma however is a rare variant of well-differentiated squamous cell carcinoma with limited metastatic potential. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.2029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452454PMC
April 2019
1 Read

Synchronous non-collision melanoma and basal cell carcinoma arising from chronic lymphedema: a case report and review of literature.

J Surg Case Rep 2019 Apr 12;2019(4):rjz105. Epub 2019 Apr 12.

Department of General Surgery, Brandon Regional Hospital, Brandon, FL 33511, USA.

Chronic lymphedema (CL) due to failure of lymphatic drainage harbors an immunologically vulnerable environment for the development of various neoplasms. Independently, either melanoma or basal cell carcinoma (BCC) arising from CL has only been reported, but synchronous melanoma and BCC originating from CL is never reported. We report a very rare case of synchronous melanoma and BCC arising from the lymphedematous upper extremity developed secondary to axillary lymphadenectomy for breast cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jscr/rjz105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460899PMC
April 2019
1 Read

Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.

Oncologist 2019 Apr 17. Epub 2019 Apr 17.

Sjögren's Syndrome and Salivary Gland Dysfunction Unit, National Institutes of Health, Baltimore, Maryland, USA.

Background: The objective of this study was to characterize the clinicopathologic features of sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy.

Subjects, Materials, And Methods: Consecutive patients with new or worsening xerostomia in the setting of ICI treatment for benign or malignant neoplastic disease were evaluated, including labial salivary gland biopsy (LSGB).

Results: Twenty patients (14 male; median age 57 years) had metastatic melanoma ( = 10), metastatic carcinoma ( = 6), or recurrent respiratory papillomatosis ( = 4) and were being treated with avelumab ( = 8), nivolumab ( = 5), pembrolizumab ( = 4), nivolumab/ipilimumab ( = 2), and M7824, a biologic targeting programmed cell death ligand 1 (PD-L1) and transforming growth factor ß ( = 1). Read More

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2018-0823DOI Listing
April 2019
3 Reads

Rudhira/BCAS3 couples microtubules and intermediate filaments to promote cell migration for angiogenic remodeling.

Mol Biol Cell 2019 Apr 17:mbcE18080484. Epub 2019 Apr 17.

Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore-560064, India.

Blood vessel formation requires endothelial cell (EC) migration that depends on dynamic remodeling of the cytoskeleton. Rudhira/Breast Carcinoma Amplified Sequence 3 (BCAS3) is a cytoskeletal protein essential for EC migration and sprouting angiogenesis during mouse development and implicated in metastatic disease. Here, we report that Rudhira mediates cytoskeleton organization and dynamics during EC migration. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1091/mbc.E18-08-0484DOI Listing

Chronic Tyrosine Kinase Inhibitor (TKI) use in metastatic Renal Cell Carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?

Expert Rev Anticancer Ther 2019 Apr 17. Epub 2019 Apr 17.

g Queen Elizabeth Hospital Birmingham , Birmingham , UK.

Introduction: Patients with metastatic renal cell carcinoma (mRCC) are commonly treated with tyrosine kinase inhibitors (TKIs). An adverse effect frequently suffered by patients is lethargy, which often leads to dose reduction or drug cessation. We aimed to assess whether hypogonadism is related to treatment with TKIs. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2019.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2019.1609355DOI Listing
April 2019
3 Reads

Mucin-Containing Rectal Carcinomas: Overview of Unique Clinical and Imaging Features.

AJR Am J Roentgenol 2019 Apr 17:1-9. Epub 2019 Apr 17.

3 Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

The purpose of this study is to review the unique clinical and imaging features of mucin-containing rectal carcinomas. Mucinous rectal carcinoma is an uncommon tumor subtype with a worse prognosis. At MRI, it is marked by T2-hyperintense extracellular mucin. Read More

View Article

Download full-text PDF

Source
https://www.ajronline.org/doi/10.2214/AJR.18.20864
Publisher Site
http://dx.doi.org/10.2214/AJR.18.20864DOI Listing
April 2019
1 Read

Lenvatinib: A Review in Hepatocellular Carcinoma.

Drugs 2019 Apr 16. Epub 2019 Apr 16.

Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.

Lenvatinib (Lenvima) is an oral small molecule inhibitor of multiple receptor tyrosine kinases, and is approved for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC) in the USA, EU, Japan and China. The approval of lenvatinib was based on results of the randomized, open-label, multinational, non-inferiority phase III REFLECT trial in patients with unresectable HCC, who had not received treatment for advanced disease. In REFLECT, lenvatinib was non-inferior, but not superior, to sorafenib (current standard of care) for overall survival (OS). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-019-01116-xDOI Listing

Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.

Stem Cell Rev 2019 Apr 16. Epub 2019 Apr 16.

Amity Institute of Biotechnology, Amity University, Mumbai-Pune Expressway, Bhatan, Panvel, Mumbai, Maharashtra, 410206, India.

Since last two decades, the major cancer research has focused on understanding the characteristic properties and mechanism of formation of Cancer stem cells (CSCs), due to their ability to initiate tumor growth, self-renewal property and multi-drug resistance. The discovery of the mechanism of acquisition of stem-like properties by carcinoma cells via epithelial-mesenchymal transition (EMT) has paved a way towards a deeper understanding of CSCs and presented a possible avenue for the development of therapeutic strategies. In spite of years of research, various challenges, such as identification of CSC subpopulation, lack of appropriate experimental models, targeting cancer cells and CSCs specifically without harming normal cells, are being faced while dealing with CSCs. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12015-019-09887-2
Publisher Site
http://dx.doi.org/10.1007/s12015-019-09887-2DOI Listing
April 2019
1 Read

Significance of Intramural Metastasis in Patients with Esophageal Squamous Cell Carcinoma: An Indicator of Aggressive Cancer Behavior.

World J Surg 2019 Apr 16. Epub 2019 Apr 16.

Department of Gastroenterological Surgery, Gastroenterology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Background: Intramural metastasis (IM) is occasionally noted in patients with esophageal squamous cell carcinoma (ESCC). However, few recent studies have investigated the clinicopathological characteristics of IM and its survival impact. The present study aimed to clarify the clinicopathological and prognostic significance of IM in patients with ESCC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-019-05004-zDOI Listing
April 2019
1 Read

MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.

Cancer Immunol Immunother 2019 Apr 16. Epub 2019 Apr 16.

Department of Dermatology, University Clinic Essen, Essen, Germany.

Background: Merkel cell carcinoma (MCC) is an aggressive skin cancer in which PD-1/PD-L1 blockade has shown remarkable response rates. However, a significant proportion of patients shows primary or secondary resistance against PD-1/PD-L1 inhibition, with HLA class-I downregulation and insufficient influx of CD8 T cells into the tumor as possible immune escape mechanisms. Histone deacetylase inhibitors (HDACi) have been demonstrated to reverse low HLA class-I expression caused by epigenetic downregulation of the antigen machinery (APM) in vitro and in pre-clinical models in vivo. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02341-9DOI Listing
April 2019
1 Read

Acute adrenal haemorrhage in two cats with aldosterone-secreting adenocarcinomas.

JFMS Open Rep 2019 Jan-Jun;5(1):2055116919840828. Epub 2019 Apr 3.

Valentine Charlton Cat Centre, University Veterinary Teaching Hospital, Sydney School of Veterinary Science, Faculty of Science, University of Sydney, NSW, Australia.

Case Summary: Two 13-year-old domestic shorthair cats were diagnosed with unilateral right adrenocortical carcinomas (ACCs) and primary hyperaldosteronism (PHA). Both had polyuria, polydipsia and weight loss, and developed severe anaemia from an episode of acute adrenal haemorrhage. In one case, this occurred during hospitalisation and treatment of severe muscle weakness with cervical ventroflexion, while the other cat had acute collapse at home. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/2055116919840828
Publisher Site
http://dx.doi.org/10.1177/2055116919840828DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449812PMC
April 2019
2 Reads

The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components.

J Oncol 2019 12;2019:3671268. Epub 2019 Mar 12.

Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Background: Gastric adenocarcinoma patients with a neuroendocrine (NE) component are frequently observed in routine practice. Several previous studies have investigated the influence of a NE component on the survival of these patients; however, the results were inconsistent.

Methods: We retrospectively investigated a consecutive series of 95 gastric adenocarcinoma patients with a NE component and 190 gastric adenocarcinoma patients without a NE component. Read More

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/jo/2019/3671268/
Publisher Site
http://dx.doi.org/10.1155/2019/3671268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434268PMC
March 2019
2 Reads

MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition.

Onco Targets Ther 2019 28;12:2323-2333. Epub 2019 Mar 28.

Department of Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, People's Republic of China,

Aim: The aim of this study was to detect the effects and potential mechanisms of microRNA-221 on a series of biological behaviors of papillary thyroid carcinoma (PTC) cells in vitro and in vivo.

Methods: First, we analyzed the relationship between the expression of miR-221 and several clinicopathological features of PTC patients and then detected the expression of the miR-221 in tumor tissues and cell lines. The effects of miR-221 on proliferation and invasion of PTC cells were verified by cell counting kit-8 (CCK-8) assay, wound healing assay and transwell assay. Read More

View Article

Download full-text PDF

Source
https://www.dovepress.com/microrna-221-promotes-papillary-th
Publisher Site
http://dx.doi.org/10.2147/OTT.S190364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445232PMC
March 2019
1 Read

Hormone Receptors and Human Epidermal Growth Factor (HER2) Expression in Fine-Needle Aspirates from Metastatic Breast Carcinoma - Role in Patient Management.

J Cytol 2019 Apr-Jun;36(2):94-100

Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait.

Introduction: Estrogen receptors (ER), progesterone receptors (PR), and epidermal growth factor (HER2) are prognostic and predictive factors for breast carcinoma. We determined them by immunohistochemistry (IHC) on cell blocks from fine-needle aspirates (FNA) of metastatic breast carcinoma to axillary lymphnodes and compared them with that reported in the primary breast carcinoma (PBC) to document any change in their expression for future management.

Materials And Methods: ER, PR, and HER2 by IHC and HER2 oncogene by fluorescent in-situ hybridization (FISH) were studied on cell blocks of FNA of axillary lymphnodes in 53 of 94 PBC cases from 2012 to 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/JOC.JOC_117_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425780PMC
April 2019
1 Read

Towards individualized therapy for metastatic renal cell carcinoma.

Nat Rev Clin Oncol 2019 Apr 16. Epub 2019 Apr 16.

Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Over the past decade, the treatment landscape for patients with metastatic renal cell carcinoma (RCC) has evolved dramatically. The therapeutic options available have expanded and now include immune-checkpoint inhibitors, novel targeted agents and combination strategies, and thus optimal patient selection and treatment sequencing are increasingly pertinent for optimizing clinical outcomes. A better understanding of the underlying biology of the tumour and its microenvironment continues to drive the inception of new diagnostic and therapeutic approaches. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0209-1DOI Listing
April 2019
1 Read

Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature.

World J Surg Oncol 2019 Apr 16;17(1):70. Epub 2019 Apr 16.

Radiotherapy Department, Centre Paul Strauss, UNICANCER, 3, rue de la Porte de l'hôpital, F-67065, Strasbourg, France.

Background: Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor's capacity for relapse and to develop distant metastases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-019-1596-6DOI Listing

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma.

BMC Cancer 2019 Apr 16;19(1):360. Epub 2019 Apr 16.

Department of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China, 610041.

Background: In clinical practice, the detection of biomarkers is mostly based on primary tumors for its convenience in acquisition. However, immune checkpoints may express differently between primary and metastatic tumor. Therefore, we aimed to compare the differential expressions of PD-1, PD-L1 and PD-L2 between the primary and metastatic sites of renal cell carcinoma (RCC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5578-4DOI Listing
April 2019
1 Read

[Progression of diagnosis and treatment of medullary thyroid carcinoma].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019 Apr;54(4):306-310

Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China.

To review and summarize recent update on preoperative diagnostic criteria, treatment and postoperative follow-up for medullary thyroid carcinoma. The relevant literatures and guidelines about medullary thyroid carcinoma were analyzed and summarized. In the early stages of the disease radical surgery still dominated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1673-0860.2019.04.015DOI Listing
April 2019
2 Reads

[Outcome of neck dissection for 154 cN0/cN1 patients with squamous cell carcinoma of hypopharynx and prognostic analysis].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019 Apr;54(4):272-279

Department of Otorhinolaryngology, Eye Ear Nose and Throat Hospital of Fudan University, Shanghai 200031, China.

To determine the relationship between nodal disease distribution patterns and oncological outcome and optimum management of cN0/cN1 patients with hypopharyngeal squamous cell carcinoma (HPSCC). The collected clinical data and the follow-up disease-free survival (DFS) information from 154 patients with HPSCC treated between 2001 and 2014 in Eye Ear Nose and Throat Hospital of Fudan University were retrospectively analyzed. Kaplan-Meier method was used to calculate DFS rate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1673-0860.2019.04.007DOI Listing

Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Induces Intracellular Ca Release through the Two-Pore Channel TPC1 in Metastatic Colorectal Cancer Cells.

Cancers (Basel) 2019 Apr 15;11(4). Epub 2019 Apr 15.

Laboratory of General Physiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Nicotinic acid adenine dinucleotide phosphate (NAADP) gates two-pore channels 1 and 2 (TPC1 and TPC2) to elicit endo-lysosomal (EL) Ca release. NAADP-induced EL Ca signals may be amplified by the endoplasmic reticulum (ER) through the Ca-induced Ca release mechanism (CICR). Herein, we aimed at assessing for the first time the role of EL Ca signaling in primary cultures of human metastatic colorectal carcinoma (mCRC) by exploiting Ca imaging and molecular biology techniques. Read More

View Article

Download full-text PDF

Source
https://www.mdpi.com/2072-6694/11/4/542
Publisher Site
http://dx.doi.org/10.3390/cancers11040542DOI Listing
April 2019
1 Read

The Prognostic Roles of Pretreatment Circulating Tumor Cells, Circulating Cancer Stem-Like Cells, and Programmed Cell Death-1 Expression on Peripheral Lymphocytes in Patients with Initially Unresectable, Recurrent or Metastatic Head and Neck Cancer: An Exploratory Study of Three Biomarkers in One-time Blood Drawing.

Cancers (Basel) 2019 Apr 15;11(4). Epub 2019 Apr 15.

Chang Gung University, College of Medicine, Taoyuan 333, Taiwan.

Circulating tumor cells (CTCs) and immune status are strongly related to cancer prognosis, although few studies have examined both factors. This prospective observational study (ClinicalTrials.gov: NCT02420600) evaluated whether CTCs, circulating cancer stem-like cells (cCSCs), and peripheral lymphocytes with/without Programmed cell death protein 1 (PD-1) expression were associated with prognosis among patients receiving palliative chemotherapy for initially unresectable, recurrent/metastatic head and neck squamous cell carcinoma (rmHNSCC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11040540DOI Listing

HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-mediated Anti-tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.

Hepatology 2019 Apr 16. Epub 2019 Apr 16.

Department of Pathology, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.

Histone deacetylase 6 (HDAC6) uniquely endows as tumor suppressor in hepatocellular carcinogenesis, but the underlying mechanisms leading to tumor suppression are not fully understood. To identify comprehensive microRNAs (miRNAs) regulated by HDAC6 in hepatocellular carcinogenesis, differential miRNA expression analysis of HDAC6-transfected Hep3B cells was performed. Using integrative analyses of publicly available transcriptome data and miRNA target prediction, we selected 5 candidate miRNAs and, through in vitro functional validation, showed that let-7i-5p specifically suppressed thrombospondin-1 (TSP1) in hepatocellular carcinoma (HCC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30657DOI Listing
April 2019
1 Read

Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.

Eur J Endocrinol 2019 Apr 1. Epub 2019 Apr 1.

M Terzolo, Department of Clinical and Biological Sciences, Azienda Ospedaliero Universitaria San Luigi Gonzaga, Orbassano, Italy.

Objective: Many patients with adrenocortical carcinoma (ACC) suffer from tumor recurrence despite radical surgery. Evidence on the post-operative use of mitotane is controversial and no predictors of response are available. We aimed to assess whether adjuvant mitotane treatment may prolong survival in patients with non-metastatic ACC following complete resection and whether ACC patients at high risk of recurrence may benefit from treatment. Read More

View Article

Download full-text PDF

Source
https://eje.bioscientifica.com/view/journals/eje/aop/eje-18-
Publisher Site
http://dx.doi.org/10.1530/EJE-18-0923DOI Listing
April 2019
2 Reads

Impact of tumor size on cancer specific mortality after local tumor ablation in T1a renal cell carcinoma.

J Endourol 2019 Apr 16. Epub 2019 Apr 16.

University of Montreal Health Center, Cancer Prognostics and Health Outcomes Unit, Montreal, Quebec, Canada.

Introduction Institutional studies suggested that tumor size (TS) might be an independent predictor of recurrence after local tumor ablation (LTA). However, limited data exist to ascertain whether larger TS may also predispose to worse cancer-specific mortality (CSM). Materials and methods Patients treated with LTA for T1a non-metastatic RCC were identified within the SEER database (2004-2015). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2019.0179DOI Listing
April 2019
1 Read

Prevalence and Associated Impacts of Cervical Esophageal Clearance Issues Post Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC).

Dysphagia 2019 Apr 15. Epub 2019 Apr 15.

School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.

At present, the nature and extent of upper esophageal stage clearance issues following nonsurgical management of nasopharyngeal cancer (NPC) is not well elucidated. The aim of this study was to conduct an initial retrospective study of the prevalence and severity of upper esophageal clearance impairments in a cohort of patients post-NPC management. A secondary aim was to explore any observed relationship between severity of impairment with both (a) aspiration and (b) temporal oropharyngeal swallowing measures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00455-019-10007-yDOI Listing
April 2019
1 Read

Upstaging papillary lesions to carcinoma on surgical excision is not impacted by patient race.

Breast Dis 2019 Apr 10. Epub 2019 Apr 10.

Division of Surgical Pathology, Mercy Hospital and Medical Center, 2525 Michigan Avenue, Chicago, IL, USA.

Background: The management of papillary lesions is controversial with studies showing different rates of upstaging to malignancy. There is a paucity of research into race as an independent risk factor. The aim of this study is to identify if race is correlated with upstaging to malignancy with a secondary focus of analyzing for other personal and tumor specific risk factors for upstaging. Read More

View Article

Download full-text PDF

Source
https://www.medra.org/servlet/aliasResolver?alias=iospress&a
Publisher Site
http://dx.doi.org/10.3233/BD-180379DOI Listing
April 2019
1 Read

Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program.

Clin Genitourin Cancer 2019 Feb 20. Epub 2019 Feb 20.

Clinical Hospital Number 1 of Poznan University of Medical Sciences, Poznan, Poland.

Background: Cabozantinib is an approved treatment for metastatic renal cell carcinoma (mRCC). This report presents an analysis of the safety profile and efficacy of cabozantinib in an unselected population from Poland.

Patients And Methods: Patients with mRCC, who had been treated with at least 1 previous agent targeting the vascular endothelial growth factor pathway, were eligible to receive cabozantinib at a once-daily dose of 60 mg orally, according to the Managed Access Program (MAP). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.02.002DOI Listing
February 2019
1 Read

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma.

Pathology 2019 Apr 12. Epub 2019 Apr 12.

Aquesta Specialised Uropathology, Brisbane, Qld, Australia; University of Queensland School of Medicine, Brisbane, Qld, Australia.

Heterogeneity of tumour grading is common in clear cell renal cell carcinoma (ccRCC). WHO/ISUP grading specifies that RCC should be graded based on the highest grade present in at least one high power field. This does not take into account the proportion of high grade tumour present in a cancer, which may itself influence outcome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2019.01.004DOI Listing
April 2019
1 Read

Evergreen influenza - Tackling an old enemy with fresh munitions.

Biomed J 2019 Feb;42(1):1-4

Anders Lund Group, BRIC Biotech Research & Innovation Centre, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen, Denmark. Electronic address:

This special edition of the Biomedical Journal puts the innate immune system into the limelight. We learn about the universal mechanisms underlying the immediate defense against influenza viruses mounted by innate immunity but also its detrimental secondary effects and how differential host genetics influence the network. Moreover, this issue addresses how oral hygiene is a concern for the entire organism, that younger age goes well with neoadjuvant chemotherapy for breast cancer and zinc with feeling less distressed by tinnitus caused by noise-induced hearing loss, and that IL-1Ra holds very promising potential to prevent intestinal ischemia reperfusion injury. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23194170193013
Publisher Site
http://dx.doi.org/10.1016/j.bj.2019.02.005DOI Listing
February 2019
2 Reads

Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas.

Syst Rev 2019 Apr 15;8(1):96. Epub 2019 Apr 15.

Gustave Roussy, Service de Biostatistiques et d'Épidémiologie and Ligue Nationale Contre le Cancer Meta-Analysis Platform, Université Paris-Saclay, F-94805, Villejuif, France.

Background: This study aimed at applying the restricted mean survival time difference (rmstD) as an absolute outcome measure in a network meta-analysis and comparing the results with those obtained using hazard ratios (HR) from the individual patient data (IPD) network meta-analysis (NMA) on the role of chemotherapy for nasopharyngeal carcinoma (NPC) recently published by the MAC-NPC collaborative group (Meta-Analysis of Chemotherapy [CT] in NPC).

Patients And Methods: Twenty trials (5144 patients) comparing radiotherapy (RT) with or without CT in non-metastatic NPC were included. Treatments were grouped in seven categories: RT alone (RT), induction CT followed by RT (IC-RT), RT followed by adjuvant CT (RT-AC), IC followed by RT followed by AC (IC-RT-AC), concomitant chemoradiotherapy (CRT), IC followed by CRT (IC-CRT), and CRT followed by AC (CRT-AC). Read More

View Article

Download full-text PDF

Source
https://systematicreviewsjournal.biomedcentral.com/articles/
Publisher Site
http://dx.doi.org/10.1186/s13643-019-0984-xDOI Listing
April 2019
1 Read

Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma.

Int J Mol Sci 2019 Apr 4;20(7). Epub 2019 Apr 4.

Department of Pathology, University Hospital, 35000 Rennes, France.

Renal cell carcinoma encompass distinct diseases with different pathologic features and distinct molecular pathways. Immune checkpoint inhibitors targeting the programmed death receptor ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) pathway alone or in combination have greatly changed clinical management of metastatic renal cell carcinoma, now competing with antiangiogenic drugs in monotherapy for first-line treatment. However, long-term response rates are low, and biomarkers are needed to predict treatment response. Read More

View Article

Download full-text PDF

Source
https://www.mdpi.com/1422-0067/20/7/1692
Publisher Site
http://dx.doi.org/10.3390/ijms20071692DOI Listing
April 2019
3 Reads

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?

Cancers (Basel) 2019 Apr 3;11(4). Epub 2019 Apr 3.

Department of Radiation Oncology, Rämistrasse 100, University Hospital Zurich, 8091 Zürich, Switzerland.

With an increased understanding of the tumor biology of squamous cell carcinoma of the head and neck (SCCHN), targeted therapies have found their way into the clinical treatment routines against this entity. Nevertheless, to date platinum-based cytostatic agents remain the first line choice and targeting the epidermal growth factor-receptor (EGFR) with combined cetuximab and radiation therapy remains the only targeted therapy approved in the curative setting. Investigation of immune checkpoint inhibitors (ICI), such as antibodies targeting programmed cell death protein 1 (PD-1) and its ligand PD-L1, resulted in a change of paradigms in oncology and in the first approval of new drugs for treating SCCHN. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11040472DOI Listing
April 2019
1 Read

Detection and quantification of VEGFR-1 in the nuclei of tumor cells by a new flow cytometry-based method.

J Immunotoxicol 2019 Dec;16(1):74-81

a Laboratory of Experimental Diagnostics and Biotherapy of Tumors, Research Institute of Experimental Diagnostics and Therapy of Tumors, N. N. Blokhin National Medical Research Center of Oncology , Ministry of Health of Russia , Moscow , Russia.

Flow cytometry using fluorescent antibodies (FC) is the method of choice for the quantitation of proteins expressed at the surface or inside the cell, but, however, does not allow to selectively measure nuclear expression. We therefore sought to develop a method for the extraction of intact cell nuclei, which can be used for their subsequent immunofluorescent analysis by FC. The studied protein was vascular endothelial growth factor-receptor-type 1 (VEGFR-1) which is important in tumor survival and metastasis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1547691X.2019.1598522DOI Listing
December 2019
4 Reads